Deferred Tax Assets, Valuation Allowance of REGENTIS BIOMATERIALS LTD. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
REGENTIS BIOMATERIALS LTD. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • REGENTIS BIOMATERIALS LTD. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $11,109,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

REGENTIS BIOMATERIALS LTD. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $11,109,000 +$2,153,000 +24% 31 Dec 2025 20-F/A 27 Feb 2026 2025 FY
Q4 2024 $8,956,000 31 Dec 2024 20-F/A 27 Feb 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.